Please wait while we load the requested 10-K report or click the link below:
https://last10k.com/sec-filings/report/1625288/000149315219014714/form10-k.htm
SEC Filings
NXEN Annual Reports
NXEN Quarterly Reports
10-Q Quarterly Report May 2022
10-Q Quarterly Report February 2022
10-Q Quarterly Report May 2021
10-Q Quarterly Report February 2021
10-Q Quarterly Report November 2020
10-Q Quarterly Report May 2020
10-Q Quarterly Report February 2020
10-Q Quarterly Report November 2019
10-Q Quarterly Report May 2019
10-Q Quarterly Report February 2019
10-Q Quarterly Report May 2022
10-Q Quarterly Report February 2022
10-Q Quarterly Report May 2021
10-Q Quarterly Report February 2021
10-Q Quarterly Report November 2020
10-Q Quarterly Report May 2020
10-Q Quarterly Report February 2020
10-Q Quarterly Report November 2019
10-Q Quarterly Report May 2019
10-Q Quarterly Report February 2019
NXEN Corporate News
Financial Exhibit
New Agreement
New Financial Obligation
Unregistered Sales January 2022
Financial Exhibit
Regulated Disclosure July 2020
Event for Officers April 2020
Event for Officers October 2019
Financial Exhibit
Regulated Disclosure July 2019
Event for Officers April 2019
Vote of Security Holders March 2019
Financial Exhibit
Regulated Disclosure March 2019
Financial Exhibit
Regulated Disclosure March 2019
Financial Exhibit
Regulated Disclosure February 2019
Financial Exhibit
New Agreement
New Financial Obligation
Unregistered Sales
New Agreement
New Financial Obligation
Unregistered Sales
January 2022
Financial Exhibit
Regulated Disclosure
Regulated Disclosure
July 2020
Event for Officers
April 2020
Event for Officers
October 2019
Financial Exhibit
Regulated Disclosure
Regulated Disclosure
July 2019
Event for Officers
April 2019
Vote of Security Holders
March 2019
Financial Exhibit
Regulated Disclosure
Regulated Disclosure
March 2019
Financial Exhibit
Regulated Disclosure
Regulated Disclosure
March 2019
Financial Exhibit
Regulated Disclosure
Regulated Disclosure
February 2019
Last10K.com | 10-K Annual Report Mon Sep 30 2019
Document and Entity Information - USD ($) | 12 Months Ended | ||
|---|---|---|---|
Jun. 30, 2019 | Sep. 25, 2019 | Dec. 31, 2018 | |
| Document And Entity Information | |||
| Entity Registrant Name | NEXIEN BIOPHARMA, INC. | ||
| Entity Central Index Key | 0001625288 | ||
| Document Type | 10-K | ||
| Document Period End Date | Jun. 30, 2019 | ||
| Amendment Flag | false | ||
| Current Fiscal Year End Date | --06-30 | ||
| Entity a Well-known Seasoned Issuer | No | ||
| Entity a Voluntary Filer | No | ||
| Entity Reporting Status Current | Yes | ||
| Entity Interactive Data Current | Yes | ||
| Entity Filer Category | Non-accelerated Filer | ||
| Entity Small Business Flag | true | ||
| Entity Emerging Growth Company | true | ||
| Entity Ex Transition Period | false | ||
| Entity Shell Company | false | ||
| Entity Public Float | $ 2,826,071 | ||
| Entity Common Stock, Shares Outstanding | 53,984,004 | ||
| Document Fiscal Period Focus | FY | ||
| Document Fiscal Year Focus | 2019 |
View differences made from one year to another to evaluate Nexien Biopharma, Inc.'s financial trajectory
Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Nexien Biopharma, Inc..
Assess how Nexien Biopharma, Inc.'s management team is paid from their Annual Proxy
Nexien Biopharma, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:
- Voting Procedures
- Board Members
- Executive Team
- Salaries, Bonuses, Perks
- Peers / Competitors
SEC Filing Tools
Financial Statements, Disclosures and Schedules
Inside this 10-K Annual Report
Document And Entity Information
Consolidated Balance Sheets
Consolidated Balance Sheets (Parenthetical)
Consolidated Statement Of Stockholders' Equity
Consolidated Statement Of Stockholders' Equity (Parenthetical)
Consolidated Statements Of Cash Flows
Consolidated Statements Of Operations
Commitments And Contingencies
Income Taxes
Income Taxes (Details Narrative)
Income Taxes (Tables)
Income Taxes - Schedule Of Deferred Tax Asset And Valuation Account (Details)
Income Taxes - Schedule Of Deferred Tax Asset And Valuation Account (Details) (Parenthetical)
Income Taxes - Schedule Of Income Tax Expense (Details)
License Agreements
License Agreements (Details Narrative)
Nature Of Business And Basis Of Presentation
Nature Of Business And Basis Of Presentation (Details Narrative)
Prepaid Expenses
Prepaid Expenses (Tables)
Prepaid Expenses - Schedule Of Prepaid Expenses (Details)
Related Party Transactions
Related Party Transactions (Details Narrative)
Share Exchange Agreement
Share Exchange Agreement (Details Narrative)
Stockholders' Equity
Stockholders' Equity (Details Narrative)
Stockholders' Equity (Tables)
Stockholders' Equity - Schedule Of Common Stock From The Exercise Of Warrants (Details)
Stockholders' Equity - Schedule Of Fair Value Of Stock Options Assumptions (Details)
Stockholders' Equity - Schedule Of Stock Option Activity (Details)
Stockholders' Equity - Summary Of Warrant Activity (Details)
Subsequent Events
Subsequent Events (Details Narrative)
Summary Of Significant Accounting Policies
Summary Of Significant Accounting Policies (Policies)
Material Contracts, Statements, Certifications & more
Nexien Biopharma, Inc. provided additional information to their SEC Filing as exhibits
Ticker: NXEN
CIK: 1625288
Form Type: 10-K Annual Report
Accession Number: 0001493152-19-014714
Submitted to the SEC: Mon Sep 30 2019 6:06:17 AM EST
Accepted by the SEC: Mon Sep 30 2019
Period: Sunday, June 30, 2019
Industry: Pharmaceutical Preparations
External Resources:
Stock Quote
Social Media
Bookmark the Permalink: https://last10k.com/sec-filings/nxen/0001493152-19-014714.htm
SEC Filing Exhibit
PDF Download
Loading SEC Filing Exhibit...
Excel DownloadLoading SEC Filing Financial Summary...